A prospective, randomized study comparing cefepime and imipenem-cilastatin in the empirical treatment of febrile neutropenia in patients treated for haematological malignancies

Scandinavian Journal of Infectious Diseases
Honar CherifMats Kalin

Abstract

A prospective, open label, randomized, multicentre study was conducted, comparing the efficacy and safety of cefepime with that of imipenem-cilastatin for the management of febrile neutropenia in patients with haematological malignancies. Furthermore, the safety of early discontinuation of antibiotic therapy in patients with fever of undetermined origin (FUO) was assessed. A total of 180 patients with 207 febrile episodes were randomized at start of fever (105 episodes for cefepime and 102 episodes for imipenem). The 2 groups were comparable in terms of age, gender, underlying malignancy, prior transplantation, and presence of central venous catheters. All patients were neutropenic at inclusion with median absolute neutrophil count (ANC) 0.1 x 10(9)/l(range 0-1 x 10(9)/l), and ANC < or = 0.1 x 10(9)/l in 77% of included patients. The mean duration of neutropenia, with ANC < 0.5 x 10(9)/l was 6.2 d. Febrile episodes were classified as microbiologically documented infection (47%), FUO (43%), or clinically documented infection (10%). At final evaluation 1-2 weeks after completion of antibiotic therapy, monotherapy success rates were 40% and 51% in the cefepime and imipenem-cilastatin groups respectively (p = 0.33). The 4-week over...Continue Reading

References

Jan 1, 1976·Scandinavian Journal of Infectious Diseases·N MortensenN I Nissen
Jan 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A G FreifeldR C Young
Jun 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·K KanellakopoulouP Sfikakis
Dec 1, 1996·The Annals of Pharmacotherapy·M A Wynd, J A Paladino
Jan 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C CordonnierJ J Gres
Aug 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L S EltingG P Bodey
Oct 28, 1998·Scandinavian Journal of Infectious Diseases·R LindbladI Turesson
Aug 16, 2000·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J KlasterskyJ Talcott
Sep 12, 2000·The Annals of Pharmacotherapy·P H Chandrasekar, P M Arnow
Feb 19, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Walter T HughesLowell S Young
Mar 1, 1996·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·Antoine AndremontMonique G. L
Nov 26, 2002·American Journal of Hematology·K TamuraUNKNOWN Kyushu Hematology Organization for Treatment (K-HOT) Study Group

❮ Previous
Next ❯

Citations

Jan 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of Americaa
Jan 25, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alison G Freifeld Infectious Diseases Society of America
Feb 5, 2010·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Masaki FujitaUNKNOWN Lung Oncology Group in Kyushu (LOGIK)
Dec 20, 2008·The Lancet Infectious Diseases·Trent G TowneKelly Echevarria
Apr 24, 2007·The Lancet Infectious Diseases·Dafna YahavLeonard Leibovici
Jan 12, 2013·Pharmacotherapy·Frank P TverdekRoy F Chemaly
Sep 12, 2009·Pediatrics International : Official Journal of the Japan Pediatric Society·Sema VuralRejin Kebudi
Oct 15, 2013·Transplant Infectious Disease : an Official Journal of the Transplantation Society·B J McCulloughJ R Wingard
Aug 12, 2015·The Clinical Respiratory Journal·Yusuke MoriyamaTakeshi Kaneko
Dec 10, 2013·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·J-B MicolB Gachot
Mar 6, 2007·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Zeina A KanafaniSouha S Kanj
May 25, 2016·International Journal of Antimicrobial Agents·Konstantinos Z VardakasMatthew E Falagas
Jun 27, 2013·The Cochrane Database of Systematic Reviews·Reineke A SchootMarianne D van de Wetering
Feb 20, 2018·Infectious Diseases·Florence PasquierJean-Baptiste Micol
Jan 20, 2012·The Cochrane Database of Systematic Reviews·Anat Gafter-GviliLeonard Leibovici
Apr 1, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S J EdwardsC E Emmas
Mar 3, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·L GómezJ Garau
Dec 14, 2005·The Journal of Antimicrobial Chemotherapy·Mical PaulLeonard Leibovici
Nov 12, 2010·The Cochrane Database of Systematic Reviews·Mical PaulLeonard Leibovici
Mar 20, 2019·The Cochrane Database of Systematic Reviews·Rodolfo Rivas-RuizSilvia Rivas-Contreras
May 3, 2019·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Clyde D FordDaanish Hoda
Jan 26, 2021·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Trang D TrinhSarah B Doernberg
Mar 5, 2019·International Journal of Antimicrobial Agents·Zoé Van de WyngaertSerge Alfandari

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.